Compare Bank Central Asia Tbk (BBCA) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank Central Asia Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Bank Central Asia Tbk trades at Rp6,350 (market cap 774.97T), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B). The key difference: Bank Central Asia Tbk is far larger — about 1646.8× Prodia Diagnostic Line Tbk's market cap. Which is the better fit depends on your goals.
| BBCA | PRDL | |
|---|---|---|
Market Cap | 774.97T | 470.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank Central Asia Tbk
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →About Prodia Diagnostic Line Tbk
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →
